Background illustration for clinical trials search

Leukemia Clinical Trials

Browse 1,314 Leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia, in Relapse,
Location: New York NY, Houston TX, La Jolla CA, Los Angeles CA
Sponsor: Bio-Path Holdings, Inc.

Sex: All

Age: 18+

Code: NCT05190471

Phase1, Recruiting

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

for
B-cell Acute Lymphoblastic Leukemia
Location: Boston MA, New Haven CT, Hackensack NJ, Wilmington DE,
Sponsor: Pediatric Transplantation & Cellular Therapy Consortium

Sex: All

Age: 1 - 25

Code: NCT03509961

Phase2, Recruiting

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

for
AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia,
Location: Fairfax VA, Durham NC, Tyler TX, Houston TX, Dallas TX,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04358393

Phase1, Phase2, Recruiting

Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

for
Hematologic Cancer, Relapse Leukemia, Relapsed Adult ALL,
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal

Sex: All

Age: 18 - 65

Code: NCT03091933

Phase1, Phase2, Recruiting

Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies

for
NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia,
Location: Houston TX, Portland OR, San Francisco CA
Sponsor: Athenex, Inc.

Sex: All

Age: 3 - 70+

Code: NCT05487651

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

for
B-cell Acute Lymphoblastic Leukemia,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 0 - 25

Code: NCT04746209

Phase2, Recruiting

A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

for
Chronic Lymphocytic Leukemia (CLL),
Location: Milwaukee WI
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06788639

Recruiting

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

for
Acute Myeloid Leukemia (AML)
Location: Miami FL, Canton OH, Cincinnati, OH, Fairway KS,
Sponsor: Aptevo Therapeutics

Sex: All

Age: 18+

Code: NCT06634394

Phase1, Recruiting

Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor

for
Multiple Myeloma, Lymphoma, Acute Myelogenous Leukemia,
Location: Denver CO
Sponsor: Colorado Blood Cancer Institute

Sex: All

Age: 50 - 70

Code: NCT00304720

Phase2, Recruiting

Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy

for
Acute Myeloid Leukemia, Elderly
Location: Kansas City MO
Sponsor: Kansas City Veteran Affairs Medical Center

Sex: All

Age: 60+

Code: NCT00728520

Phase2, Recruiting
New

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

for
Anxiety Disorders, Stress Disorders, Post-Traumatic,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: Female

Age: 18 - 70+

Code: NCT07540585

Recruiting
New

Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

for
HIV
Location: New York NY, Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT07665372

Recruiting
New

A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

for
Human Papilloma Virus (HPV),
Location: Little Rock AR, Layton UT, Phoenix AZ, Seattle WA
Sponsor: Daré Bioscience, Inc.

Sex: Female

Age: 22 - 50

Code: NCT07601074

Phase2, Recruiting
New

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

for
HER2-negative Breast Cancer, Hormone Receptor Positive Tumor,
Location: Port Huron MI, Mount Clemens MI, Detroit MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 22+

Code: NCT07227831

Recruiting
New

To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

for
Locally Advanced or Metastatic HER2-Expressing Cancers
Location: Duarte CA
Sponsor: Vir Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT05356741

Phase1, Phase2, Recruiting
New

Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

for
HIV, Substance Use Disorder (SUD)
Location: Lexington KY
Sponsor: Johns Hopkins Bloomberg School of Public Health

Sex: All

Age: 18+

Code: NCT07804121

Recruiting
New

A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

for
HIV -1 Infection
Location: Houston TX
Sponsor: BioNTech SE

Sex: All

Age: 18 - 50

Code: NCT07698600

Phase1, Recruiting
New

Expanding HOPE Liver

for
HIV Infection, Liver Transplant
Location: New York NY, Baltimore MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT07778459

Recruiting
New

Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care

for
Cervical Cancer, HIV
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 25 - 49

Code: NCT06850402

Recruiting

Safety Study of MucoCept-CVN

for
HIV -1 Infection
Location: San Francisco CA
Sponsor: Craig Cohen, MD, MPH

Sex: Female

Age: 18 - 45

Code: NCT07181486

Phase1, Recruiting

What are clinical trials for leukemia?

Clinical trials for leukemia are research studies designed to evaluate new treatments, therapies, or diagnostic methods for different types of leukemia, a group of cancers that affect the blood and bone marrow. These trials aim to discover more effective ways to treat leukemia, manage its symptoms, and improve patient outcomes. They may involve testing new drugs, combinations of existing treatments, targeted therapies, immunotherapies, or novel approaches like gene therapy.

Why are leukemia clinical trials important?

Leukemia clinical trials are crucial because they drive advancements in treatment by testing new therapies, improving existing ones, and exploring novel approaches to manage and potentially cure the disease. These trials provide essential data on the safety and effectiveness of new treatments, which can lead to better outcomes and fewer side effects compared to current options.

Types of clinical trials for leukemia

Why participate in a leukemia clinical trial

Who can participate in a clinical trial for leukemia?

How to enroll in a leukemia clinical trial